drugset / Trial / NCT00825617

Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

NCT00825617

Completed 16 enrolled University of Aarhus
RandomizedCrossoverOpen-labelTreatment

Summary

Several studies have demonstrated that Turner Syndrome patients have elevated liver enzymes readily suppressible by a short course of HRT. We wanted to estimated quantitative liver functions in a young group of Turner syndrome patients compared to a healthy control group.

Timeline

Start
1996-10
Primary completion
1999-10
Completion
2000-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 2 mg Oral
Subject Norethindrone Unknown 1 mg Oral

Indications